Stock ALTME TME PHARMA N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders TME Pharma N.V.

Equities

ALTME

NL0015000YE1

Market Closed - Euronext Paris
Other stock markets
 11:35:08 2024-05-08 EDT 		5-day change 1st Jan Change
0.254 EUR -0.39% Intraday chart for TME Pharma N.V. +4.31% +10.43%
04-25 TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-23 TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biotech Group TMA Pharma's CFO to Leave by 2022-end
MT
TME Pharma N.V. Announces Executive Changes
CI
TME Pharma N.V. Announces the Resignation of Bryan Jennings as Chief Financial Officer
CI
French Drugmaker Noxxon Changes Name to TME Pharma
MT
NOXXON Pharma N.V. Announces Resignation of Gregory Weaver from its Supervisory Board, Effective September 30, 2022
CI
NOXXON Pharma N.V. has Changed its Name to TME Pharma N.V
CI
Noxxon Pharma N.V. Announces Scientific Advisory Board Appointments
CI
NOXXON Pharma N.V. Announces Appointment of Bryan Jennings as Additional Statutory Director
CI
NOXXON Pharma N.V. Appoints Bryan Jennings as Chief Financial Officer, Effective November 1, 2021
CI
Noxxon Pharma N.V. Announces Board Changes
CI
Noxxon Pharma N.V. Announces Resignation of Members of the Supervisory Board
CI
NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board
CI
NOXXON Pharma N.V. Appoints Jose Saro as Chair of Scientific Advisory Board
CI
NOXXON Pharma N.V. Appoints Dr. C. A. Izeboud to the Supervisory Board
CI
NOXXON Pharma N.V. Appoints Dr. Maurizio Petitbon as Chairman
CI
NOXXON Pharma N.V. Announces Board Changes
CI
NOXXON Pharma N.V. Announces Executive Changes
CI
NOXXON Pharma Appoints Don deBethizy to the Supervisory Board
CI
Noxxon Pharma Appoints Don Munoz as Chief Financial Officer
CI
NOXXON Pharma AG Appoints Don Munoz as Chief Financial Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALTME Stock
  4. News TME Pharma N.V.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW